Navigation Links
Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution
Date:10/2/2009

BOSTON, Oct. 2 /PRNewswire/ -- Massachusetts General Hospital (MGH) Cancer Center has purchased four radiation therapy treatment systems from Elekta, including three Elekta Infinity and one Elekta Synergy® S. The order, which includes information management software, will enable the facility to offer patients a complete cancer treatment solution from the company.

The three Infinity systems position MGH to take advantage of Volumetric Modulated Arc Therapy (VMAT), a new radiation therapy technique that allows clinicians to deliver tightly focused radiation treatments in less time. A treatment session typically can be conducted in five minutes or less and delivered with single or multiple arcs depending upon the patients needs.

Elekta Infinity also supports all forms of Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).

MGH also purchased Elekta Synergy S, a state-of-the-art digital linear accelerator with integrated imaging capabilities. The facility will use Elekta Synergy S to perform Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) throughout the body, as well as hypofractionated treatments utilizing IGRT and VMAT.

The four treatment machines also feature the HexaPOD(TM) evo RT system, a vision guided patient positioning platform with six degrees of freedom. Six degrees of freedom means that the system can detect and correct misalignments in patient positioning --making it ideal for the very high accuracy required during critical radiation treatments.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated
'/>"/>

SOURCE Elekta
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
2. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
3. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
4. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
5. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
6. Allegheny General Hospital Performs First Liver Transplant
7. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
8. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
9. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
10. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
11. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... , Jan. 23, 2015 Tianyin Pharmaceutical Inc. ... that specializes in the development and sale of patented ... and active pharmaceutical ingredients (API) today announced the business ... API operation. 1. Following the September 2014 ...
(Date:1/22/2015)... 2015  BiOptix is pleased to announce the appointment of ... Chemistry and Biochemistry. Scott joins the company after previous scientific ... throughout the course of his nearly 20 year career ... a nationally recognized thought leader in the biosensor field ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce ... ever created for kids with cancer. The Chemo Duck App, available ... filled with enjoyable games to help children of all ages living ... helps to keep kids entertained, educated and at ease while waiting ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... to a new study, patients with lung disease suffered more ... Texas studied a group of 200 patients with chronic obstructive ... steroids, to manage their condition, for a period of four ... received a placebo inhaler for the next five months. ...
... a report, giving radiation to surgical treatment for rectal ... of patients. But the findings suggest that the radiation ... quality of life by reducing the rate of cancer ... the rectum. ,In about 15% to 45% of ...
... to cook food. At first the cooked food was probably provided ... dominates our tables. Even now, centuries later, our taste buds do ... course arrives or at home as a filler,no meal is complete ... from the usual salads of cucumber - tomato - onion etc., ...
... cytomegalovirus could be involved in the development of colon ... colon cancer, the majority of cases arise for no ... have now exposed a link between viral infection and ... studies that show how human cytomegalovirus (CMV) can disrupt ...
... with high levels of hostility have a greater risk of ... Researchers in the US conducted a survey of 720 men, ... and the world around them.// They also asked them about ... weight to hip ratio. ,They found that among ...
... high blood pressure is a major factor accounting for ... well known that black people live, on average, six ... not complete //high school are at a similar disadvantage ... time, a study has identified the major health factors ...
Cached Medicine News:Health News:Keep fit with salads 2Health News:Keep fit with salads 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: